191 related articles for article (PubMed ID: 23157178)
1. Therapeutic potential of amniotic fluid stem cells.
Abdulrazzak H; De Coppi P; Guillot PV
Curr Stem Cell Res Ther; 2013 Mar; 8(2):117-24. PubMed ID: 23157178
[TBL] [Abstract][Full Text] [Related]
2. Stem cells derived from amniotic fluid: new potentials in regenerative medicine.
Cananzi M; Atala A; De Coppi P
Reprod Biomed Online; 2009; 18 Suppl 1():17-27. PubMed ID: 19281660
[TBL] [Abstract][Full Text] [Related]
3. Stem cells from amniotic fluid--Potential for regenerative medicine.
Loukogeorgakis SP; De Coppi P
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():45-57. PubMed ID: 26542929
[TBL] [Abstract][Full Text] [Related]
4. Human amniotic fluid stem cells: a new perspective.
Siegel N; Rosner M; Hanneder M; Freilinger A; Hengstschläger M
Amino Acids; 2008 Aug; 35(2):291-3. PubMed ID: 17710362
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid-derived stem cells in regenerative medicine research.
Joo S; Ko IK; Atala A; Yoo JJ; Lee SJ
Arch Pharm Res; 2012 Feb; 35(2):271-80. PubMed ID: 22370781
[TBL] [Abstract][Full Text] [Related]
6. Effect of Human Amniotic Fluid Stem Cells on Kidney Function in a Model of Chronic Kidney Disease.
George SK; Abolbashari M; Kim TH; Zhang C; Allickson J; Jackson JD; Lee SJ; Ko IK; Atala A; Yoo JJ
Tissue Eng Part A; 2019 Nov; 25(21-22):1493-1503. PubMed ID: 30829146
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells.
Benavides OM; Petsche JJ; Moise KJ; Johnson A; Jacot JG
Tissue Eng Part A; 2012 Jun; 18(11-12):1123-31. PubMed ID: 22250756
[TBL] [Abstract][Full Text] [Related]
8. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.
Romani R; Pirisinu I; Calvitti M; Pallotta MT; Gargaro M; Bistoni G; Vacca C; Di Michele A; Orabona C; Rosati J; Pirro M; Giovagnoli S; Matino D; Prontera P; Rosi G; Grohmann U; Talesa VN; Donti E; Puccetti P; Fallarino F
J Cell Mol Med; 2015 Jul; 19(7):1593-605. PubMed ID: 25783564
[TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy.
Antonucci I; Stuppia L; Kaneko Y; Yu S; Tajiri N; Bae EC; Chheda SH; Weinbren NL; Borlongan CV
Cell Transplant; 2011; 20(6):789-95. PubMed ID: 21054947
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic beta-cells.
Trovato L; De Fazio R; Annunziata M; Sdei S; Favaro E; Ponti R; Marozio L; Ghigo E; Benedetto C; Granata R
J Endocrinol Invest; 2009 Dec; 32(11):873-6. PubMed ID: 19574730
[TBL] [Abstract][Full Text] [Related]
11. Stem Cells Derived from Amniotic Fluid: A Potential Pluripotent-Like Cell Source for Cellular Therapy?
Ramasamy TS; Velaithan V; Yeow Y; Sarkar FH
Curr Stem Cell Res Ther; 2018; 13(4):252-264. PubMed ID: 29336267
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
13. Molecular signature of human amniotic fluid stem cells during fetal development.
Moschidou D; Drews K; Eddaoudi A; Adjaye J; De Coppi P; Guillot PV
Curr Stem Cell Res Ther; 2013 Jan; 8(1):73-81. PubMed ID: 23270629
[TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid stem cells: an ideal resource for therapeutic application in bone tissue engineering.
Pantalone A; Antonucci I; Guelfi M; Pantalone P; Usuelli FG; Stuppia L; Salini V
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2884-90. PubMed ID: 27424990
[TBL] [Abstract][Full Text] [Related]
15. Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility.
Lai D; Wang F; Chen Y; Wang L; Wang Y; Cheng W
BMC Dev Biol; 2013 Sep; 13():34. PubMed ID: 24006896
[TBL] [Abstract][Full Text] [Related]
16. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications.
Loukogeorgakis SP; De Coppi P
Stem Cells; 2017 Jul; 35(7):1663-1673. PubMed ID: 28009066
[TBL] [Abstract][Full Text] [Related]
18. CD117(+) amniotic fluid stem cells: state of the art and future perspectives.
Cananzi M; De Coppi P
Organogenesis; 2012; 8(3):77-88. PubMed ID: 23037870
[TBL] [Abstract][Full Text] [Related]
19. Expression of mTOR pathway proteins in human amniotic fluid stem cells.
Siegel N; Valli A; Fuchs C; Rosner M; Hengstschläger M
Int J Mol Med; 2009 Jun; 23(6):779-84. PubMed ID: 19424604
[TBL] [Abstract][Full Text] [Related]
20. Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.
Kunisaki SM
Organogenesis; 2012; 8(3):89-95. PubMed ID: 22986340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
